Andrew N J Tutt

Andrew N J Tutt

UNVERIFIED PROFILE

Are you Andrew N J Tutt?   Register this Author

Register author
Andrew N J Tutt

Andrew N J Tutt

Publications by authors named "Andrew N J Tutt"

Are you Andrew N J Tutt?   Register this Author

24Publications

1085Reads

23Profile Views

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells.

Front Immunol 2018 23;9:493. Epub 2018 Mar 23.

St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.00493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876289PMC
April 2019

Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.

J Allergy Clin Immunol 2018 04 31;141(4):1519-1523.e9. Epub 2018 Jan 31.

St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, United Kingdom; NIHR Biomedical Research Centre at Guy's and St Thomas's Hospitals and King's College London, London, United Kingdom; Breast Cancer Now Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2017.12.986DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286379PMC
April 2018

Driver Oncogenes but Not as We Know Them: Targetable Fusion Genes in Breast Cancer.

Cancer Discov 2018 03;8(3):272-275

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-18-0091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372062PMC
March 2018

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.

Front Immunol 2017 10;8:1911. Epub 2018 Jan 10.

St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.01911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767725PMC
January 2018

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.

PLoS One 2016 10;11(5):e0155391. Epub 2016 May 10.

Department of Biochemistry, Molecular Biology, and Biophysics, Institute for Molecular Virology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155391PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862684PMC
July 2017

Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors.

Annu Rev Med 2015 17;66:455-70. Epub 2014 Oct 17.

The Breakthrough Breast Cancer Research Center, The Institute of Cancer Research, London, United Kingdom and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-050913-022545DOI Listing
September 2015

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.

Cancer Discov 2015 May 13;5(5):488-505. Epub 2015 Mar 13.

Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-1092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490184PMC
May 2015

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Breast Cancer Res 2013 Oct 1;15(5):R92. Epub 2013 Oct 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907091PMC
October 2013

Signatures of mutational processes in human cancer.

Nature 2013 Aug 14;500(7463):415-21. Epub 2013 Aug 14.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776390PMC
August 2013

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.

Cancer Cell 2008 Feb;13(2):91-104

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2008.01.001DOI Listing
February 2008

BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potency.

Cancer Biol Ther 2005 Sep 1;4(9):934-6. Epub 2005 Sep 1.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.4.9.2141DOI Listing
September 2005

DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells.

EMBO Rep 2004 Oct 10;5(10):989-93. Epub 2004 Sep 10.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://embor.embopress.org/cgi/doi/10.1038/sj.embor.7400255
Publisher Site
http://dx.doi.org/10.1038/sj.embor.7400255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299155PMC
October 2004

Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation.

EMBO Rep 2002 Mar 15;3(3):255-60. Epub 2002 Feb 15.

The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/embo-reports/kvf037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010PMC
March 2002